Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Action of Aclidinium Bromide in COPD
NCT00435760Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2007
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Feb 2007; status: completed.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00435760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435760.